News | Cardiovascular Ultrasound | August 28, 2026

GE HealthCare Debuts Next Generation of Vivid Cardiovascular Ultrasound Portfolio

Vivid Explorer, Vivid Advanced and Vivid Focus systems bring cSound imaging with capabilities designed for routine echocardiography, comprehensive cardiac imaging and interventional care.

GE HealthCare Debuts Next Generation of Vivid Cardiovascular Ultrasound Portfolio

Vivid Explorer (Photo: GE HealthCare)


Aug. 28, 2026 — GE HealthCare has announced three additions to its Vivid cardiovascular ultrasound portfolio — Vivid Explorer1, Vivid Advancedand Vivid Focus1 — each designed to address distinct imaging and workflow needs across a range of cardiology care settings. The systems will be showcased at the European Society of Cardiology (ESC) Congress 2026 in Munich, Germany.

The number of people living with cardiovascular disease worldwide has doubled since 1991.2 As cardiovascular care spans routine echocardiography, complex diagnostic assessments and image-guided procedures, care teams need technology that can support different clinical environments while providing a consistent imaging and user experience. Vivid Explorer, Vivid Advanced and Vivid Focus join the ultra-premium system Vivid Pioneer, broadening the portfolio and bringing Vivid’s image quality, workflow and familiar user interface to further support settings where cardiovascular care happens. 

“The imaging needs of an echo lab, a cardiology practice, and an interventional environment are not the same, and we’ve spent a lot of time with care teams in each of those settings to understand where technology can make the greatest difference,” said Jyoti Gera, CEO, CardioVascular and Interventional Solutions, Advanced Imaging Solutions, GE HealthCare. “Developing Vivid Explorer, Vivid Advanced and Vivid Focus on the same foundation as Vivid Pioneer allows us to meet these unique needs while creating a more connected family of systems that deliver Vivid performance and the Vivid experience.”

With these introductions, the Vivid family includes four systems built on a common technology foundation, with each system designed for different needs across cardiovascular care:

  • Vivid Pioneer: GE HealthCare’s ultra-premium cardiovascular ultrasound system for the most complex cases
  • Vivid Explorer: Designed for high-volume echo labs and routine interventional procedures, with advanced 4D, multi-plane and 2D imaging across transthoracic echocardiography (TTE), transesophageal echocardiography (TEE) and intracardiac echocardiography (ICE), along with AI and automation capabilities supporting advanced cardiac workflows
  • Vivid Advanced: Designed for busy mid-size hospitals and cardiology practices that need comprehensive cardiac imaging—including 2D TTE, multi-plane TEE and 2D ICE—together with vascular, abdominal and soft-tissue imaging
  • Vivid Focus: Brings cSound imaging technology to a system designed for everyday cardiac imaging, along with the new 4Sc-RS probe, AI-enabled workflow tools and support for vascular, abdominal and soft-tissue exams
  • Vivid iq: Offers enhanced performance and portability, combining advanced imaging capabilities with flexibility. The laptop-sized ultrasound system is equipped with a wide range of imaging capabilities and advanced quantification tools for cardiovascular, abdominal, and musculoskeletal exams

Extending the Vivid experience beyond the ultrasound system, the latest version of EchoPAC Software Only v2113 introduces the same new capabilities available across Vivid Explorer, Vivid Advanced and Vivid Focus. The advanced cardiovascular ultrasound analysis and reporting platform enables clinicians to review, analyze and quantify studies on-site or remotely using consistent tools and workflows across image acquisition, analysis and reporting.

Common Ultrasound Foundation

All three new Vivid systems use cSound, the software-based imaging architecture shared across the Vivid portfolio. cSound imaging technology is designed to help optimize contrast, resolution and tissue visualization through advanced processing, supporting a consistent imaging experience across the Vivid family.

The systems also include AI-enabled and automation tools designed to streamline routine echo workflows and support consistency across users and exam types. Capabilities include AI Auto Measure 2D, Easy AutoEF, Easy AFI LV and AI Cardiac Auto Doppler, which are designed to help reduce manual steps and simplify measurements such as ejection fraction. 

A familiar Vivid interface and highly adjustable ergonomics are designed to support workflow continuity across systems. Vivid Explorer, Vivid Advanced and Vivid Focus also offer battery-supported operation and Power Saving Mode to help clinicians move between clinical environments and reduce energy use while maintaining performance.

Enabling the Cardiology Care Pathway

At ESC 2026, GE HealthCare will feature the Vivid family as a key part of its cardiology solutions spanning ECG, ultrasound, advanced imaging, image-guidance, recording and cardiovascular reporting - reflecting the company’s continued focus on helping heart care teams increase collaboration, automate workflows and gain deeper clinical insights across the cardiovascular care pathway.

Featured solutions will include the Revolution™ Vibe CT system, MUSE™ NX diagnostic cardiology solution, and the Vscan Air SL ultrasound system with a cardiopulmonary suite of AI-enabled solutions, including Caption AI™. Also on display will be the ComboLab AltiX AI.i for invasive cardiology and the digital solution ViewPoint 6, powered by EchoPAC4

Vivid Explorer, Vivid Advanced, Vivid Focus and EchoPAC Software Only v211 have received CE Mark. Vivid Explorer, Vivid Advanced and Vivid Focus are U.S. FDA 510(k) pending and not available for sale in the U.S. EchoPAC Software Only v211 is also 510(k) pending with the U.S. FDA and not available for sale in the U.S.

To learn more about the Vivid family, visit: Vivid Explorer, Vivid Advanced or Vivid Focus.

 

References

  1. Vivid Explorer, Vivid Advanced and Vivid Focus are CE Marked and 510(k) pending with the U.S. FDA and not available for sale in the U.S. 

  2. British Heart Foundation, Global Cardiovascular Disease Factsheet (January 2026).

  3. EchoPAC Software Only v211 is 510(k) pending with the U.S. FDA and not available for sale in the U.S.

  4. EchoPAC functionality described herein is based on EchoPAC  v210 and earlier cleared versions. Availability of future software releases, including v211, is subject to applicable regulatory clearances and may vary by country

 

GE Healthcare Vivid Ultrasound

 

 


Related Content

News | Cardiac Imaging

Aug. 12, 2026 — Salus Scientific has launched its Clinical Insights Series, a new publication platform designed to share ...

Home August 17, 2026
Home
News | Cardiac Imaging

Aug. 12, 2026 — Ventripoint Diagnostics is expanding subscription-based access to its VMS+ 4.0, its FDA-cleared platform ...

Home August 14, 2026
Home
News | Cardiac Imaging

August 4, 2026 - Epsilon Imaging and ASCEND Cardiovascular have announced a strategic non-exclusive partnership designed ...

Home August 13, 2026
Home
Feature | Cardiac Imaging | John Memarian

The last few decades have been marked by rapid advances in cardiovascular medicine, particularly in areas like imaging ...

Home August 06, 2026
Home
News | Cardiac Imaging

August 3, 2026 — Despite improvements in technology and awareness, work-related musculoskeletal disorders (WRMSDs) ...

Home August 03, 2026
Home
News | Cardiac Imaging

June 9 2026 — With the project “Triaging artificial intelligence (AI) Tool For Pulmonary Health Using Spectral X-ray ...

Home June 12, 2026
Home
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Home May 21, 2026
Home
News | Cardiac Imaging

May 1, 2026 — On May 14, Cleerly and interventional cardiologist Neerav Sheth, MD, will present a free webinar on ...

Home May 12, 2026
Home
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Home April 29, 2026
Home
News | Cardiac Imaging

April 23, 2026 — Royal Philips has launched the next-generation Bridge Plus Occlusion Balloon, designed to help ...

Home April 23, 2026
Home
Subscribe Now